Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmace...

FDA Recall #D-0354-2023 — Class III — February 17, 2023

Recall #D-0354-2023 Date: February 17, 2023 Classification: Class III Status: Terminated

Product Description

Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05.

Reason for Recall

Presence of Foreign Tablets/Capsules: Pharmacist reported presence of some Gabapentin tablets 800 mg comingled in Gabapentin 600 mg 500 count bottles.

Recalling Firm

Sciegen Pharmaceuticals Inc — Hauppauge, NY

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

4,392 bottles

Distribution

Nationwide in the USA and Puerto Rico

Code Information

Lot # G177092, Exp. 11/24

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls